Company: XAIR
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021561
Chunk: 62

Company: Beyond Air, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 62
---
.4 million was attributed primarily to the change in fair value of the derivative
liability that was extinguished in the prior year and no fair value measurement of such instrument occurred during the current period.
Additionally, the decrease in interest expense of $0.7 million is due to the Company’s current debt facility compared to the debt
outstanding in the comparative period. The decrease in interest expense is offset by a $0.4 million decrease of dividend and investment
income.

Net
Loss Attributable to Non-controlling Interests

Net
loss attributed to non-controlling interests for the three months ended September 30, 2025, was $0.3 million, compared to $0.7 million
for the three months ended September 30, 2024. Net loss attributed to non-controlling interests for the six months ended September 30,
2025, was $0.7 million, compared to $1.5 million for the six months ended September 30, 2024. Non-controlling interests represent 20%
of the net loss of our Beyond Cancer subsidiary and 11.8% of the net loss of our NeuroNos subsidiary based on the ownership structure
during the majority of the reporting periods.

31

Net
Loss Attributed to Common Stockholders

Net
loss attributed to common stockholders of Beyond Air, Inc for the three months ended September 30, 2025, was $7.9 million or a loss of
$1.25 per share, basic and diluted. Our net loss attributed to common stockholders of Beyond Air, Inc for the three months ended September
30, 2024 was $13.4 million or a loss of $5.67 per share, basic and diluted.

Net
loss attributed to common stockholders of Beyond Air, Inc for the six months ended September 30, 2025, was $15.5 million or a loss of
$2.75 per share, basic and diluted. Our net loss attributed to common stockholders of Beyond Air, Inc for the six months ended September
30, 2024 was $25.6 million or a loss of $10.99 per share, basic and diluted.

Liquidity
and Capital Resources

Cash
Flows

Below
is a summary of our cash flows activities for the six months ended September 30, 2025 and September 30, 2024:

    Six Months Ended 

    September 30, 
  
    (